author-photo

Yoo Jin Lee

Kyungpook National University Hospital

37

Papers

112

Citations

Citation Trend

Filter By

Papers (27) Sort By

Journal Conference Others

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

2020 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (1)
1094PUse of droplet digital polymerase chain reaction for detecting minimal residual disease: A prospective, multi-institutional study

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimen

2018 Yeungnam University Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Identification of High Risk Group for Leukemic Transformation in Higher Risk MDS Patients Using Targeted RNA-Sequencing: Hematopoietic Stem Cell Signature As a High Risk Profile for Leukemic Transformation

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea

2018 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (5)
Benefit of Two Additional Cycles of Bortezomib/Thalidomide/Dexamethasone (VTD) Induction Therapy Compared to Four Cycles of VTD for Newly Diagnosed Multiple Myeloma

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

2018 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Which donor is better when a matched donor is not available domestically? Comparison of outcomes of allogeneic stem cell transplantation with haploidentical and international donors in a homogenous ethnic population

2018 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (4)
Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse

2018 Blood
Show All
- Source
- Cite
- Save
Citations (52)
Residual Allelic Burden Measured By Next-Generation Sequencing (NGS) at Remission Provides Limited Prognostic Value to Predict Relapse and Long-Term Outcome in Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)